-
Using Structured Expert Elicitation to Estimate Long-Term Organ Damage Risk in an Ultrarare Condition: A STEER Case Study
Sep 9, 2025, 16:22 PM -
Occurrence of Exacerbations and Mortality in High-Risk Chronic Obstructive Pulmonary Disease Patients While on Treatment With Dual or Triple Inhaled Therapy: Results From the SIRIUS Observational Study in the US
Sep 9, 2025, 16:22 PM -
Review of CEESP ICERs for Orphan and Nonorphan Treatments in France, 2024-2025
Sep 9, 2025, 16:22 PM -
Unmet Needs in NICE HTAs: Insights From Obesity and Diabetes Submissions
Sep 9, 2025, 16:22 PM -
CDF or CDFoe: How Has the Cancer Drugs Fund Impacted Access to Atezolizumab for Patients With Non-Small Cell Lung Cancer in the Adjuvant Setting?
Sep 9, 2025, 16:22 PM -
Reassessing NICE's Highly Specialized Technologies (HST) Criteria: A Retrospective Review of Borderline and Approved Appraisals Under the Revised Framework
Sep 9, 2025, 16:22 PM -
The Estimation of the Prevalent Presymptomatic Type 1 Diabetes Population in Germany Using a Patient Funnel Model
Sep 9, 2025, 16:22 PM -
Medical and Nonmedical Resource Utilization Associated With CIDP: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
Utility Estimates for Health States Associated With Immune Thrombocytopenia: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Trends in Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Prescribing in England: A Data Analysis Using NHS Prescription Episodes Statistics (PES)
Sep 9, 2025, 16:22 PM -
How the NHS Can Optimize Health Outcomes in a Time of Financial Constraint
Sep 9, 2025, 16:22 PM -
Natural History of Creutzfeldt-Jakob Disease: A Comparison of Manual vs. Manual Plus AI-Assisted Approaches in Literature Review
Sep 9, 2025, 16:22 PM -
Prognostic Accuracy and Clinical Effectiveness of 68Ga-PSMA-11 PET/CT (ILLUCIX®) Imaging Followed by 177-Lu-PSMA-617 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Perspectives of Patients and Caregivers on Relapsed/Refractory Acute Myeloid Leukemia Treatments: A Mixed-Methods Interview Study
Sep 9, 2025, 16:22 PM -
Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Incidence of Treatment-Related Adverse Events From Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Clinical Trials
Sep 9, 2025, 16:22 PM -
Evaluating Cost-Consequences and Digital Transformation Through Concentric Consent: An Impact Assessment at Oxford University Hospitals NHS Foundation Trust
Sep 9, 2025, 16:22 PM -
Measurement Properties of the EQ-5D in Hematological Cancers: A Systematic Review
Sep 9, 2025, 16:22 PM -
Estimating the Public Health and Economic Impact of Recombinant Zoster Vaccine (RZV) Vaccination for Adults Aged 50 and Older in South Korea
Sep 9, 2025, 16:22 PM -
Understanding Patient Priorities in Psoriasis Treatment: A Review of Key Decision-Making Drivers
Sep 9, 2025, 16:22 PM
